广州蓝勃生物科技有限公司

What 广州蓝勃生物科技有限公司 does

Guangzhou Labsim Biotech Co., Ltd. (广州蓝勃生物科技有限公司) is a privately-held Chinese medical device manufacturer founded in 2007 and headquartered at Room 425-433, Building H6, No. 39 Ruihe Road, Huangpu District, Guangzhou. The company operates with a team of approximately 12 employees and concentrates on two product verticals: point-of-care testing (POCT) immunochromatography analyzers with associated reagents, and pathology laboratory equipment including UV laser slide and tissue cassette printers. Labsim positions itself as offering the most complete POCT and Pathology product variety in the domestic Chinese market, claiming more than 100,000 hospitals and clinics use its instruments. International presence extends to Southeast Asia, South Korea, and Pakistan, anchored by reference customers including Shaukat Khanum Memorial Cancer Hospital, Gangnam-Severance Hospital, and Samsung Hospital.

The technical platform centers on automated fluorescent immunoassay detection, with multi-channel analyzers (AFS2100S provides 12 independent incubation channels) and a proprietary UV laser printing architecture for pathology products that eliminates ribbon, inkjet, and toner consumables while producing 2500-dpi corrosion-resistant prints suitable for long-term specimen storage. The immunofluorescence reagent portfolio spans infection, sex hormones, thyroid hormones, cardiac markers (cTnI, NT-proBNP, H-FABP), cancer markers (PSA, CEA), diabetes (HbA1c), kidney function (MAlb), and infectious disease test categories. Pathology products include UV-laser slide printers (G306U, G364D, G363UV), tissue cassette printers (TB406U, TB686, TB586UV), thermal printers, and microtome humidifiers, all designed with built-in Windows operating systems and LIS/HIS/PIS/PACS hospital-system compatibility.

The commercial model is direct B2B sales through an inquiry-driven website funnel with a 12-hour response commitment, managed by two sales managers (Lex Lei and Doris Chan), supplemented by WhatsApp/WeChat contact channels and participation in international exhibitions such as WHX Labs 2026 in Bangkok and MEDICA. Revenue is generated from hardware sales of analyzers and pathology printers plus recurring consumable revenue from a 30+ reagent SKUs, with CE certification obtained for at least one influenza test kit supporting potential European market entry. The company maintains a 13-language corporate website covering English, Arabic, German, Spanish, French, Hindi, Italian, Malay, Portuguese, Romanian, Russian, and Chinese to support global SEO and inbound lead generation. No funding rounds, ownership structure details, or audited financials are publicly disclosed.

Name

广州蓝勃生物科技有限公司

Legal name

Guangzhou Labsim Biotech Co.,Ltd.

Website

https://labsim-ivd.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Guangzhou Labsim Biotech Co., Ltd. (广州蓝勃生物科技有限公司) is a Chinese medical device manufacturer founded in 2007 that produces POCT immunofluorescence analyzers and UV laser pathology printers, serving over 100,000 hospitals and clinics with reagent consumables and LIS/HIS/PIS/PACS-integrated equipment.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD) Equipment

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• POCT diagnostic analyzers
• Immunofluorescence reagents
• Pathology laser printers
• In vitro diagnostics equipment
• Histopathology laboratory devices

Headquarters

HQ city

Guangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Testing Equipment Sales: Sale of POCT analyzers including immunofluorescence analyzers and colloidal gold analyzers. Equipment includes automated systems like AFS3000, L300, AFS2600B, and AFS2100S models for hospitals and clinics.
2. Diagnostic Reagent Sales: Sale of immunofluorescence reagents and colloidal gold reagents covering infection, sex hormone, thyroid hormone, cardiac marker, cancer, diabetes, kidney, and infectious disease testing categories. Reagents provide recurring revenue as consumables for installed analyzer base.
3. Pathology Products: Sale of pathology equipment including slide laser printers (G306U, G364D, G364P), tissue cassette laser printers (TB406U, TB686), slide ultraviolet printers (G363UV), tissue cassette ultraviolet printers (TB586UV), thermal printers, and microtome humidifiers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Founded in 2007, Guangzhou Labsim Biotech is a Chinese high-tech manufacturer of point-of-care testing (POCT) immunofluorescence and colloidal gold analyzers, diagnostic reagent kits covering infection, cardiac, thyroid, hormone, cancer, diabetes, and kidney markers, and a complete line of pathology laser/UV printers and tissue cassette printers for histopathology laboratories. The company sells its manufactured medical testing equipment to hospitals, clinics, pathology departments, and IVD enterprises globally, with an installed base of more than 100,000 hospitals and clinics in China.

Product overview

Guangzhou Labsim Biotech Co., Ltd. is a high-tech enterprise specializing in R&D, production, and marketing of medical testing equipment founded in 2007. The company offers a comprehensive solution of automated fluorescent immunoassay systems and pathology products. The product portfolio consists of: (1) POCT Analyzers including immunofluorescence analyzers (AFS3000, L300, AFS2600B, AFS800, AFS-1000, AFS2600) and colloidal gold analyzers; (2) Immunofluorescence Reagents covering infection, sex hormone, thyroid hormone, cardiac marker, cancer, diabetes, kidney, and infectious disease categories; (3) Colloidal Gold Reagents for sex hormones and infectious diseases; (4) Pathology Products including UV laser slide printers (G306U, G364D, G363UV), tissue cassette laser printers (TB406U, TB686, TB586UV), thermal printers (G306, TB406), and microtome humidifiers; (5) Histopathology Consumables. The company serves over 100,000+ hospitals and clinics globally with the mission 'Make Medical Test More Accurate' and 'Make Pathology Easier'.

Differentiator

Problem solved

Functional benefit

Products and services

• Automatic Fluorescence Immunoassay Analyzer AFS3000 Automated fluorescent immunoassay analyzer designed for quantitative detection of multiple biomarkers in clinical specimens at the point of care, intended for hospitals and clinical laboratories.

Quantifiable outcome

• 100,000+ hospitals and clinics using Labsim instruments
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Brady Corporation: Industrial and laboratory identification specialist with thermal and laser slide/cassette printers used in histology labs. Comparable in the pathology-printer product line Labsim offers (G306U, TB406U, TB586UV).
• Hunan Yuanjing Biotech (湖南远璟生物): Smaller Chinese POCT manufacturer offering fluorescence immunoassay analyzers and reagent kits. An emerging niche peer with overlapping product range but smaller scale than Labsim.

Direct peers

• Autobio Diagnostics (安图生物): Chinese IVD manufacturer focused on clinical chemistry, immunoassay analyzers and reagents. Comparable product breadth and Chinese hospital customer base, targeting the same mid-tier hospitals as Labsim.
• Wondfo Biotech (万孚生物): Leading Chinese POCT manufacturer with comparable immunofluorescence and colloidal-gold reagents covering infectious disease, cardiac, hormones, and oncology. Directly competes in the same Chinese hospital and emerging-market channels as Labsim.
• Hangzhou Alltest Biotech (杭州艾博生物): Emerging Chinese POCT player specializing in rapid diagnostic test kits and immunofluorescence analyzers. Direct peer in infectious-disease, fertility, and drug-of-abuse reagent categories that overlap with Labsim's test menu.
• Snibe Diagnostic (新产业生物): Shenzhen-based chemiluminescence and POCT immunoassay platform serving hospital labs globally with parallel reagent menu (thyroid, hormones, cardiac, tumor markers). Direct head-to-head competitor in the IVD analyzer-plus-reagent bundle Labsim sells.

Broad incumbents

• Sekisui Diagnostics: Global clinical chemistry and immunoassay reagent/equipment supplier. Comparable as an established IVD manufacturer pursuing mid-sized hospital accounts in similar disease categories (cardiac, infectious disease).
• Mindray (迈瑞医疗): China's largest medical device company with a sizable IVD and POCT division. Competes with Labsim across immunoassay analyzers and reagents but operates a much broader portfolio (patient monitoring, imaging, in-vitro diagnostics).
• QuidelOrtho: US-based diagnostics incumbent with a strong rapid immunoassay and POCT portfolio (e.g., Sofia, Triage) used in hospitals and clinics worldwide. Broad incumbent that overlaps with Labsim's fluorescence immunoassay business globally.
• Randox Laboratories: UK-based IVD manufacturer with broad clinical chemistry and immunoassay reagent menus plus analyzer hardware. Comparable in product-mix breadth (analyzer + reagent) and hospital-segment focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E5%B9%BF%E5%B7%9E%E8%93%9D%E5%8B%83%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 广州蓝勃生物科技有限公司